Diabetic foot: Evaluation and management

Southern Medical Journal

Volumn 95, Issue 1, 2002, Pages 95-101

  Green, Melissa F ^a   Aliabadi, Zarrintaj ^a   Green, Bryan T ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALLUS; COST EFFECTIVENESS ANALYSIS; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC FOOT; FOOT AMPUTATION; FOOT MALFORMATION; FOOT ULCER; HEALTH CARE COST; MORBIDITY; MORTALITY; MUSCLE ATROPHY; NEUROPATHIC JOINT DISEASE; PATHOGENESIS; PATHOLOGIC FRACTURE; PATIENT EDUCATION; PERIPHERAL NEUROPATHY; PHYSICAL EXAMINATION; QUALITY OF LIFE; REVIEW; RISK FACTOR;

EID: 0036165044     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200201000-00019     Document Type: Review

References (81)

1. Diabetes in America: Epidemiology and scope of the problem
2. Diabetes Trends in the US: 1990-1998
3. Clinical practice recommendations 2001. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
4. Emerging epidemic of type 2 diabetes in youth
5. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents
6. Quality of outpatient care provided to diabetic patients: A health maintenance organization experience
7. Patterns of foot inspection in a diabetes clinic
8. Physician documentation of diabetes care: Use of a diabetes flow sheet and patient education clinic
9. Assessment of documented foot examinations for patients with diabetes in inner-city primary care clinics
10. Outpatient diabetes management of Medicare beneficiaries in four Mississippi fee-for-service primary care clinics
11. Position statement: Preventive foot care in people with diabetes
12. Economic consequences of diabetes mellitus in the US in 1997
13. Medical care expenditures for diabetes, its chronic complications and its comorbidities
14. Preventive foot care in people with diabetes
15. Diabetic neuroarthropathy in the foot: Patient characteristics and patterns of radiographic change
16. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic
17. Lower extremity foot ulcers and amputations in diabetes
18. Clinical practice recommendations, screening for type 2 diabetes
19. Epidemiology of lower extremity amputation in centers in Europe, North America, and East Asia
20. Reducing lower extremity amputations due to diabetes: Application of the staged diabetes management approach in a primary care setting
21. A cost analysis of diabetic lower extremity ulcers
22. Nephropathy and neuropathy. American Diabetes Association Annual Meeting, 1999
23. The acutely infected diabetic foot is not adequately evaluated in an inpatient setting
24. Foot infections in diabetic patients: Decision and cost-effective analysis
25. Diabetic foot ulcers in a multidisciplinary setting: An economic analysis of primary healing and healing with amputation
26. Improved quality of diabetic foot care, 1984 vs 1990: Reduced length of stay and costs, insufficient reimbursement
27. Cost of treating advanced leg ischemia
28. The costs of surgery for limb-threatening ischemia
29. Variation in the incidence and proportion of diabetes related amputation in minorities
30. Rehabilitation of the older lower limb amputee: A brief review
31. Daily functioning of the lower extremity amputee: An overview of the literature
32. Functional outcome in the elderly following lower extremity amputation
33. Energy cost of walking of amputees: The influence of level of amputation
34. Energy demands for walking in dysvascular amputees as related to the level of amputation
35. Institutionalization following diabetes-related lower extremity amputation
36. Success rates for rehabilitation of vascular amputees: Implications for preoperative assessment and amputation level
37. Care of the elderly patient with lower extremity amputation
38. Diabetes mellitus
39. New concepts and insights on pathogenesis and treatment of diabetic complications: Polyol pathway and its inhibition
40. Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration
41. Screening and assigning risk to the diabetic foot
42. Lower leg, ankle, and foot
43. Treatment of foot wounds caused by pressure and insensitivity
44. Relationship between hallux limitus and ulceration of the great toe
45. Examination
46. Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings
47. Long-term prognosis after healed amputation in patients with diabetes
48. The inflammatory response to wounding
49. Recent commencement of dialysis is a risk factor for lower-extremity amputation in a high risk diabetic population
50. Nontraumatic lower-extremity amputation in the Medicare endstage renal disease population
51. Risk factors predicting lower extremity amputations in patients with NIDDM
52. Diabetic foot
53. Association between callus formation, high pressure and neuropathy in diabetic foot ulceration
54. The effect of regular callus removal on foot pressures
55. Therapeutic footwear helps protect the diabetic foot
56. Prescription inserts and footwear
57. Manufactured shoes in the prevention of diabetic foot ulcers
58. The reduction and redistribution of plantar pressures using foot orthoses in diabetic patients
59. Evaluation of the costs to medicare of covering therapeutic shoes for diabetic patients
60. American orthopedic foot and ankle society diabetic shoe survey
61. Preventing diabetic foot disease: Lessons from the medicare therapeutic shoe demonstration
62. Use of the therapeutic footwear benefit among diabetic medicare beneficiaries in three states, 1995
63. Charcot neuroarthropathy of the foot and ankle
64. Charcot foot
65. Acute charcot arthropathy in patients with diabetes mellitus: Healing times by foot location
66. Long term follow-up in diabetic Charcot feet with spontaneous onset
67. Selective neuropathy and preserved vascular responses, the diabetic Charcot foot
68. Recognition and management of neuropathic (Charcot) arthropathies of the foot and ankle
69. Is Charcot arthropathy a late sequela of osteoporosis in patients with diabetes mellitus?
70. Osteomyelitis
71. Hematogenous calcaneal osteomyelitis in children
72. Outcomes of preventive care in a diabetic foot specialty clinic
73. A systematic review of foot ulcer in patients with type 2 diabetes mellitus: Prevention
74. Effectiveness of a comprehensive diabetes lower-extremity amputation prevention (LEAP) program in a predominantly low income African hanerican population
75. Potential economic benefits of lower-extremity amputation prevention strategies in diabetes